Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Avadomide (CC-122) CAS:1015474-32-4
Avadomide (CC-122)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1640 | 50mg | 425.00 | + Add to cart |
|
| R-C-1640 | 100mg | 705.00 | + Add to cart |
|
| R-C-1640 | 200mg | 1150.00 | + Add to cart |
|
|
|
||||
Product description
Avadomide(CC-122),a new chemical entity termed pleiotropic pathway modifier,is a novel agent for Diffuse large B-cell lymphoma(DLBCL)with antitumor and immunomodulatory activity.Its molecular target is the protein cereblon(CRBN),a substrate receptor of the cullin ring E3 ubiquitin ligase complex CRL4CRBN.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---Avadomide (CC-122) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
